Robinson Value Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,700
Closed -$292K 66
2020
Q4
$292K Buy
+4,700
New +$289K 0.28% 58
2019
Q4
$302K Buy
+4,700
New +$269K 0.29% 51

Other funds holding BMY

Robinson Value Management's BMY Position: Q1 2021 in Review

Robinson Value Management sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 4,700 shares — an estimated $292K sold.

Robinson Value Management first reported a position in BMY in Q4 2019 and held it in 2 quarters. The position peaked at $302K in Q4 2019. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Robinson Value Management reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
  • Robinson Value Management sold 4,700 Bristol-Myers Squibb shares in Q1 2021, an estimated $292K.
  • Robinson Value Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 2 quarters.
  • Robinson Value Management's Bristol-Myers Squibb position peaked at $302K in Q4 2019.
  • 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Robinson Value Management's 13F filing for Q1 2021, filed 14 May 2021.